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The incidence of melanoma is rising worldwide. The American Cancer Society estimates that 76,100 new cases of melanoma will be diagnosed in the USA and 9710 people are expected to die of metastatic disease.\[[@ref1]\] Malignant melanoma (MM) has various risk factors; historically, recurrent severe sun exposure, however environmental and genetic influences also affect the incidence. Dysplastic nevi (DN) may occur sporadically or in a familial setting. In the Caucasian population, sporadic DN are identified in up to 50% of adults.\[[@ref2][@ref3]\] DN in the familial setting are estimated around 32,000 in the USA.\[[@ref4]\] Patients with DN have an increased risk of developing melanoma.\[[@ref5]\] Although patients with DN are at an increased risk for developing melanoma, their role as a precursor lesion is debated. By vast majority, melanomas arise *de novo*. Some studies have shown that up to 25% of melanomas may have an associated dysplastic nevus present, suggesting progression to become melanoma\[[@ref6][@ref7]\] although this controversial finding has not been fully substantiated in other studies.

Histologically, DN and melanoma are characterized by their architectural and cytological features. DN are on an average smaller in diameter than melanoma; however, size is not a defining factor to distinguish each entity. By definition, DN contain a junctional component, with bridging of adjacent rete ridges. The rete ridges can be uniformly or irregularly elongated. DN have bridging nests, or shouldering, whereas melanoma nests are more coalescent. However, overlapping features can be seen in both entities. Diffuse dermal fibroplasia, associated with a band-like lymphocytic infiltrate, is typically more identified in melanoma, while DN have a more concentric fibroplasia with patchy perivascular lymphocytes. Cytologically, DN should exhibit variable (mild to severe) atypia of the melanocytic cells at the dermal-epidermal junction, while melanoma can show atypia of the dermal component and significant pagetoid spread in epidermis. There is, however, significant morphological overlap between MM and DN, especially in those with severe cytological atypia, with substantial differences in patient prognosis. Pagetoid spread, increased single and confluent melanocytes at the dermal-epidermal junction, and cytological atypia can be seen in both severe DN and melanoma. Mitoses are frequently associated with melanomas, but can be observed in DN. Atypia is defined by nuclear enlargement, irregular nuclear membrane, prominent nucleoli, and coarse chromatin. Many of these histologic features, while on a spectrum, do overlap, which can be difficult to discern each diagnosis.

To complicate matters further, similar genetic mutations have been described in both MM and DN. Two melanoma-susceptibility genes include CDKN2A and BRAF. The presence of DN increases the risk of melanoma in patients with germline mutations in CDKN2A, which is the main genomic locus of melanoma susceptibility.\[[@ref8]\] Familial and germline CDKN2A mutations have been reported in DN.\[[@ref8][@ref9]\] Somatic mutations of *BRAF* have also been detected in patients with DN and primary melanomas.\[[@ref10]\] It has been postulated that BRAF mutations are the initial step in developing melanocytic neoplasia, but alone cannot develop melanoma tumorigenesis.\[[@ref11]\]

A lack of consensus between pathologists as well as the National Institutes of Health on the presence of cytological atypia (and architectural disorder) to establish a diagnosis of a dysplastic nevus promotes the need for ancillary tests to aid in diagnosis.\[[@ref12][@ref13]\] Dermatologists use diagnostic tools such as the dermascope. In patients with DN, dermascopes have been shown to increase clinical accuracy for diagnosing melanoma. However, the accuracy is highly variable and dependent on expertise and dermoscopy training.\[[@ref14]\] Experiments using comparative genomic hybridization (CGH) and fluorescence *in situ* hybridization (FISH) are also being investigated. However, these tests are not without significant cost. CGH is not widely available and requires a 3-week turnaround time. CGH estimates cost between \$800 and \$2075. FISH studies are more widely available, with a shorter turnaround time, but cost between \$1300 and \$1800.\[[@ref15]\]

Nucleotyping is based principally on chromatin structural changes that are affected by epigenetic changes and DNA binding proteins. DNA organization changes as the cell is in different states. By viewing nuclei in their interphase (and mitotic) state, pixel image data of each nucleus can be transmitted and analyzed. Studies have shown that genomic status (stable vs. unstable) correlates with prognosis, and nucleotyping is being developed to be a potential correlate of analyzing genomic instability.\[[@ref16][@ref17]\] Recently, computational methods have attracted much attention toward quantitative analysis of segmented cell or nuclear structures\[[@ref18][@ref19][@ref20][@ref21][@ref22]\] and contributed to understanding changes in DNA organization and chromatin structure with regard to cancer development. Nucleotyping including variation in nuclei shape, size, and texture can be analyzed with image analysis pipeline consisting of segmentation, feature extraction, and classification. Employing nucleotyping of textural features uses pixel data derived from the gray-level sum and difference histograms (i.e., co-occurrence matrix) and gray-level run-length matrix. This analysis uses these statistical features to analyze gray levels in the image, their pixel distances, and orientation. Markovian features quantitative gray-level data between adjacent pixels in an image (i.e., run-length, contrast, correlation, difference, entropy, peak, symmetry, etc.). Morphometry features to be analyzed include nuclear size (area, DNA density) and shape (i.e., perimeter, elongation, diameter, cell ferret). Fractal-based methods use a fractal dimension and lacunarity to measure nuclear complexity.\[[@ref23][@ref24]\] These methods have been shown to aid in the diagnosis and prognosis of some solid tumors. For instance, nucleotyping was used to develop a biomarker to measure genetic instability in prostate cancer deemed, quantitative nuclear grade (QNG). QNG has been used to predict pathologic stage of disease, recurrence risk after prostatectomy, and also for differentiation of urothelial cell grade in bladder cytology specimens.\[[@ref25][@ref26][@ref27][@ref28]\] Using multiple morphometric nuclear parameters and retrospective clinical recurrence data, a study showed darker maximum nuclear gray levels and greater variance related to basal cell carcinoma recurrence and worse disease-free survival.\[[@ref29]\] Another study has identified nuclear textural features to be an independent prognostic marker of survival in endometrial carcinoma and uterine sarcomas.\[[@ref30][@ref31]\] Many studies performing nuclear image analysis to discriminate nuclear textural features have been reportedly successful, however many have not validated on a true independent set of cases. A comprehensive review of nuclear texture analysis showed that \< 20% of studies at that time evaluated their classifiers on an independent validation set.\[[@ref32]\]

In this particular study, we describe a new computational method that differentiates DN and melanoma based on cell nuclear morphology from histopathology images. Melanocyte nuclei in the region of interest (ROI) are manually selected under the supervision of pathologists, which are then segmented automatically. The morphological characteristics for each nucleus are quantified utilizing transport-based morphometry,\[[@ref21][@ref33]\] which utilizes mathematics of the optimal transport (OT) problem in continuous domain,\[[@ref33]\] facilitating classification. [Figure 1](#F1){ref-type="fig"} shows a schematic diagram of the method. In addition to serving as a predictive model, the approach provides visual representation of distribution differences in nuclear morphology between DN and melanoma. If successful, it has the potential to develop new diagnostic, predictive, and prognostic markers for the diagnosis of melanoma, and ultimately advances patient care.

![The transport-based nuclei morphometry analysis pipeline. Cell nuclei are first identified by pathologists and segmented from region of interest in the whole slide images (a); morphological characteristics for each individual cell nucleus are represented by the obtained linear embedding utilizing the optimal transport problem (b), which are then used to find the discriminative geodesic for classification and visualization of nuclear distribution differences between malignant melanoma and dysplastic nevi (c)](JPI-8-15-g001){#F1}
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Case selection and image acquisition {#sec2-1}
------------------------------------

Under an Institutional Review Board approval, hematoxylin and eosin (H and E) slides from cases of MM and DN were retrieved from the pathology archives. Glass slides of each case were reviewed by two board-certified dermatopathologists. A total of 139 cases were included in our study, including 67 cases diagnosed with MM and 72 cases diagnosed with DN. Slides from each case were scanned with an Aperio ScanScope XT whole slide scanner at ×40 magnification (0.25 μ/pixel) and converted into digital images. The nuclear information embedded in the hematoxylin channel was recovered from RGB images with color deconvolution.\[[@ref34]\]

Nuclei segmentation {#sec2-2}
-------------------

Melanocyte nuclei were manually annotated and selected for each case. Given nuclei seeds, cell nuclei were segmented automatically using an unsupervised method.\[[@ref35]\] In brief, the nucleus edge map in Cartesian-coordinated system is first transformed into the polar space with nucleus seed being the origin. After that, the edge pixels on the nucleus contour are optimally selected by the Dijkstra\'s algorithm in a constructed shortest path problem. Blurring, overlapping, and incorrect nuclei segmentations were removed from the dataset by manual inspection. Ultimately, 11,542 melanocyte nuclei were included in the study with 5184 nuclei in the DN group and 6358 nuclei in the MM group. Each nucleus was stored in a 150 × 150 sub image with black background and bright pixels indicating the amount of locally concentrated chromatin.

Normalization {#sec2-3}
-------------

The intensity summation for each nucleus image was first normalized to be one to minimize the intensity variations in slide preparation, staining procedure, and image acquisition. Next, nuclei position variations such as rotation, translation, and coordinate inversions were eliminated by position normalization. As described in the study by Rohde *et al*.,\[[@ref36]\] nuclei were relocated to the image centers to remove translation, and the major axes for nuclei in the dataset were aligned in the same direction to eliminate arbitrary rotation. [Figure 2](#F2){ref-type="fig"} shows some sample melanocyte nuclei from benign and malignant groups after normalization.

![Sample-segmented nuclei from dysplastic nevi (a) and malignant melanoma (b). Note that the intensity of these nuclei images has been inverted (the brighter the pixel, the more chromatin) and the contrast has been stretched for better visualization](JPI-8-15-g002){#F2}

Transport-based morphometry for comparing nuclear chromatin {#sec2-4}
-----------------------------------------------------------

We utilize the transport-based method described in the studies by Daskalakis *et al*., Kolouri *et al*., and Wang *et al*.\[[@ref22][@ref33][@ref37]\] for comparing nuclear chromatin. The idea is to use the OT distance to measure the morphological differences between two nuclei, by utilizing all the intensity values. The method consists of two steps: (1) for each nucleus image, compute the transport map with respect to a reference image; (2) utilize the transport map for describing the nucleus morphometry.

As explained in earlier publications,\[[@ref22][@ref33][@ref37]\] the method has the advantage that it does not involve information loss, and features can be inverted back to a nucleus image. Thus, classifiers (or any regression method) can be visualized in image space. Here, we provide a brief overview of the method, described in continuous domain:

Given a set of segmented nuclei images, *I*~1~, *I*~2~,..., *I*~N~: Ω→*R* with Ω = \[0, 1\]^2^, the image intensities are normalized to integrate to one as described above so that the images can be treated as distributions of fixed amount of intensity. One option for the choice of reference image is the average of the nuclei image set: ![](JPI-8-15-g003.jpg) and the OT distance between the reference and a given image *I*~i~ which is mathematically defined as follows:

![](JPI-8-15-g004.jpg)

S. t. det (*Df*~i~ \[*x*\]) *I*~0~ (*f~i~* \[*x*\]) = *I~i~* (*x*)

Where, *x* is the concatenation of image coordinates including both horizontal and vertical directions. *f~i~*: Ω→Ω is a mass-preserving transform from *I*~i~ to *I*~0~ \[[Figure 3a](#F3){ref-type="fig"}\]. D*f*~i~ is the Jacobian matrix of *f*~i~. *Det* (D*f*~*i*~ \[*x*\]) is the determinant of the Jacobian of *f~i~*, as shown in [Figure 3b](#F3){ref-type="fig"}. The transport function *f*~i~ is mathematically proved to uniquely exist and can be used to reconstruct *I*~i~ from *I*~0~ by *I*~i~(*x*) = Det (*Df*~i~ \[*x*\]) *I*~0~ (*f*~i~ \[*x*\]). The morphing process from *I*~i~ to *I*~0~ controlled by *f~i~* can be viewed as changing both pixel location and intensity of *I*~0~ at the same time. The points on geodesic *f~i~* connecting *I*~0~ and *I*~i~ on the OT manifold can be interpolated by the following formula:

![Visualization of the mass-preserving map f~i~ applied to the image coordinates (a), the determinant of the Jacobian of *f*~i~ (b), and the morphing process from *I*~i~ to *I*~0~ by changing the parameter *ρ*ε \[0, 1\] (c)](JPI-8-15-g005){#F3}

*fρ*(*x*) = (1 -- *ρ*) *x* + *ρf*~i~ (*x*), *ρ* ϵ \[0, 1\]

The morphing process from *I*~0~ to *I*~i~ can be visualized by det (*DFρ* \[*x*\]) *I*~0~ (*fρ* \[*x*\]), which is shown in [Figure 3c](#F3){ref-type="fig"}. The OT geodesic *f*~i~ can be further decomposed into the identity part *x* and the OT displacement part *u*i (*x*), denoted as *f*~i~ (*x*) = *x* +*u*i (*x*). As described in the study by Kolouri *et al*.,\[[@ref33]\] the function ![](JPI-8-15-g006.jpg) provides a natural isometric linear embedding for image *I*~i~, which quantifies the morphological characteristics of each nucleus. The linear embedding *p*~i~ is the feature representation which can be used for both classification as well as visualization of nuclear distribution differences between benign and malignant groups.

The OT metric not only measures the relative amount of chromatin in certain local regions compared with the reference nucleus image, but also provides a reversible process, where one can reconstruct the nucleus image given the corresponding linear embedding and the reference image \[[Figure 3](#F3){ref-type="fig"}\].

Classification {#sec2-5}
--------------

To perform nuclei classification, we utilized the standard Fisher linear discriminant analysis (LDA) to construct a one-dimensional subspace which is discriminative for classification. Mathematically, we want to find a linear discriminative vector which can differentiate cell nuclei with their linear embedding. The linear optimal transportation (LOT) embedding for the training dataset can be transformed into such linear subspace, where the class means are well separated, measured relative to the summation of data variances within each class. Given a set of linear embedding, ![](JPI-8-15-g007.jpg) for nuclei images *I*~1~,..., *I*~N~ and their corresponding binary class labels, the projection vector can be computed and denoted as. ![](JPI-8-15-g008.jpg) The projection for nucleus *I*~i~ along ![](JPI-8-15-g008.jpg) is computed as ![](JPI-8-15-g009.jpg). For any nucleus *I*~j~ in the testing set with linear embedding *p*~j~, the projection is similarly obtained as ![](JPI-8-15-g010.jpg). The class label for *I*~j~ can be predicted through the K-nearest neighbor (KNN) algorithm. The label for a test patient is assigned by the majority voting strategy based on the labels of its pertaining nuclei.\[[@ref38]\]

Visualization {#sec2-6}
-------------

The obtained linear embedding for each nucleus can be viewed as an invertible transform. That is, any point *p*~i~ in the high-dimensional LOT space can be transformed back to image space through *I*~i~ = det (D*f*~i~ \[*x*\]) I~0~ (*f*~i~\[*x*\]) with the mass-preserving map *f*~i~. In practice, the number of data points is usually less than the dimension of the LOT space. Thus, principal component analysis (PCA) is first applied to such that the data are represented in a lower dimensional space with the size being the number of the data points. Let the *S* be the scatter matrix with element *S*~kl~ being:

![](JPI-8-15-g011.jpg)

where, ![](JPI-8-15-g012.jpg) is mean displacement filed in the dataset.

The corresponding eigenvalues and eigenvectors can be computed through:

*Se*~i~= *γ*~i~*e*~i~, I = 1,..., N

The PCA direction with regard to can be computed as follows:

![](JPI-8-15-g013.jpg)

The mass-preserving map *f*^d,i^ along the i^th^ prominent direction can be computed through: *f*^d,\ i^ = *x* + (*ū* + *dσ*~i~*v*~i~), where, σ~i~ is the standard deviation of data projections on *v*~i~ and *d* is an integer determining the "distance" between the current displacement field and the mean displacement field. Specially, when d = 0, *f*^0,\ i^ = *x* + *ū* = *f̄*. The reconstructed image corresponding to *f*^d,\ i^ can be obtained through: det(*Df*^d,i^ (*x*)) *I*~0~ (*f*^d,i^ (*x*)). In the PCA space, each nucleus image *I*~k~ is represented by the corresponding linear embedding with reduced dimension:

*Z*~k~\[*i*\] = ∫~Ω~ *v*~i~(*x*)*u*~x~ (*x*) dx, i=1, ..., *N*, *z*^k^ Є *R*^*N*×1^

To visualize the discriminative information in the dataset with two classes (benign and malignant in our case), we apply the method described in the study by Wang *et al*.,\[[@ref39]\] namely penalized LDA (pLDA), to a set of linear embedding ![](JPI-8-15-g014.jpg) in the PCA-derived space. Given the class label *C* for each *Z*~i~, the pLDA direction WpLDA onto which the data projections of different classes are separated is obtained by solving the problem below:

![](JPI-8-15-g015.jpg)

Where, *S*~T~ = ∑~i~ (*Z*~i~ − *Z̄*)(*Z*~i~ − *Z̄*)^T^ is the scatter matrix and *S*~w~ = ∑~c~ ∑~Zi∋c~ (*z* − *Z̄*~c~)(*z* − *Z̄*~c~)^T^ is the within-class scatter matrix with Z̄c being the center of class *c*. The penalty weight represents the trade-off between the standard LDA and PCA directions.\[[@ref38]\] In the experiment, was selected by measuring the stability of the pLDA subspace.\[[@ref22]\] The discriminative direction in LOT embedding space is given by: ![](JPI-8-15-g016.jpg). By changing the integer *d*, the discriminative information along V~pLDA~ around the mean displacement field can be visualized by: ![](JPI-8-15-g017.jpg), where ![](JPI-8-15-g018.jpg) and σ is the standard deviation after data projection along V~pLDA~.

R[esults]{.smallcaps} {#sec1-3}
=====================

To evaluate the performance of the proposed method, we predicted the class labels (DN or MM) for test patients after the computation of linear embedding, representing the morphology of segmented nuclei and then compared the predicted labels with actual diagnoses. Our experiment utilized the standard leave-one-patient-out validation scheme, whereby cell nuclei pertaining to one patient were removed from the dataset and kept as testing data. In the training stage, the training data were further split into training and validation sets to search for the optimal *k* in the KNN algorithm. The one-dimensional pLDA subspace was constructed using the LOT embedding and class labels in the training data. In our case, the discriminative direction was computed and applied to obtain the projections of the testing data samples. The binary labels for individual testing nucleus were given by the KNN algorithm, and the label for any test patient was assigned through the majority voting strategy (taking the most common label assignment among its pertaining nuclei).

For comparison purpose, we also tested the performance of the numerical feature-based method described in a study by Basu *et al*.\[[@ref21]\] The morphology of each nucleus was represented using a 256-dimensional numerical feature vector, including six morphological features (area, convexity, circularity, perimeter, eccentricity, and equivalent diameter), 220 texture features (intensity-based features, Haralick features, and Gabor features), and thirty wavelet features. Similar to the classification procedure for OT-based method, the LDA technique was first applied to the derived feature matrix to find the discriminative direction, which was then used in label prediction for test patients together with the KNN algorithm and majority voting strategy. [Table 1](#T1){ref-type="table"} shows a summary of classification results by our proposed method and the numerical feature-based method. As we can see from the confusion matrices table, our LOT-based method is clearly superior compared with numerical feature-based method with 6.4% gain \[[Table 1](#T1){ref-type="table"}\].

###### 

Confusion matrices for linear optimal transportation-based method (in bold) and numerical feature-based method

![](JPI-8-15-g019)

Our method enables direct visualization of the discriminant information embedded in cell nuclei from benign and malignant groups. Visual comparisons of nuclei morphology for DN versus MM are shown in [Figure 4](#F4){ref-type="fig"}. The nuclei morphological information in the held out data (30% of data) was visually plotted along the first pLDA direction, computed based on linear embedding in the PCA space and corresponding labels in the training set. In [Figure 4](#F4){ref-type="fig"}, the height of each histogram bar indicates the proportion of nuclei most similar to the representative image beneath it. The row of representative images is the visual representation along the discriminant geodesic path by pLDA. These representatives are generated between every unit of standard deviation from the mean image along the derived direction V~pLDA~. The *P* value for differentiating data points between benign and malignant groups after projection is zero within numerical precision, indicating that DN and MM are significantly different in nuclei morphological distribution \[[Figure 4](#F4){ref-type="fig"}\].

![Histograms of nuclei morphological distributions for dysplastic nevi (white bars) and malignant melanoma (dark bars). Note that the intensity of the representative images beneath the histogram bars has been inverted with brighter pixels indicating more locally accumulated chromatin](JPI-8-15-g020){#F4}

As far as biological interpolation shown in [Figure 4](#F4){ref-type="fig"}, the most important information in discriminating DN and MM is the chromatin distribution patterns inside the nuclei as well as the nuclei size. In comparison with MM, it is uncommon for DN nuclei to have a chromatin distribution centered at the nuclei periphery; on the contrary, nuclei of DN tend to have more uniform chromatin distributions. To show this, we measured the ratio between mean intensity of pixels around the nuclei membrane and mean intensity of the remaining central area inside the nuclei and plotted ratio distributions for both DN and MM groups in [Figure 5](#F5){ref-type="fig"}. As one can see from the ratio distributions, MM nuclei tend to show higher proportions in high membrane/center ratios compared to the nuclei in DN group, which corresponds with the discriminating nuclei patterns between DN and MM in [Figure 4](#F4){ref-type="fig"}. In a study by Massi and LeBoit\[[@ref40]\] atypical melanocyte nuclei in MM are larger and the chromatin is coarser, with an irregular nuclear membrane, while stereotypical benign melanocytes have evenly distributed chromatin and rounder nuclear membrane. From the perspective of cell biology, the DNA exists in the nucleus in two forms: heterochromatin and euchromatin, reflecting the level of activity of cell. Heterochromatin is darkly stained (bright if the intensity is inverted) by H and E staining, usually scattered throughout the nucleus or adjacent to the nuclear envelope, and is typical of quiescent nuclei. Euchromatin, on the contrary, is not readily stainable and is prevalent in cells that are active in gene transcription.\[[@ref41]\] Therefore, our finding agrees with the fact that benign cell nuclei appear more heterochromatic and malignant cell nuclei appear more euchromatic, and thus the approximately "ring shape" nuclear appearance in MM relative to the nuclei in DN \[[Figure 5](#F5){ref-type="fig"}\].

![Histograms of membrane/center ratio distributions for dysplastic nevi (white bars) and malignant melanoma (black bars)](JPI-8-15-g021){#F5}

In addition, as observed from [Figure 4](#F4){ref-type="fig"}, a greater number of MM nuclei are relatively bigger than the nuclei in DN group. We also plotted the histogram of nuclei size distribution for both DN and MM groups, as shown in [Figure 6](#F6){ref-type="fig"}. The average nuclei size is 647.04 (in pixels) for MM group, compared with the average nuclei size of 543.07 in DN group, demonstrating that our proposed method can capture and visualize the distribution differences in nuclei size between the two classes \[[Figure 6](#F6){ref-type="fig"}\].

![Histograms of nuclei size distributions for dysplastic nevi (white bars) and malignant melanoma (black bars). The mean sizes for nuclei from dysplastic nevi and malignant melanoma are 543.07 pixels and 647.04 pixels, respectively](JPI-8-15-g022){#F6}
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========================

Melanocytic lesions are among the most challenging areas in surgical pathology and are a significant proportion of dermatopathology daily case volume. The lack of consensus between pathologists, significant morphological overlap as well as similar gene mutations between MM and DN make clinical diagnosis complicated.

We have described a novel image analysis method to quantify the characteristics of nuclei morphology to differentiate benign (DN) and MM melanocytic lesions. The cell nuclei were segmented from manually located ROI in H and E stained WSI. The LOT-based method then describes the characteristics of morphology of each nucleus by the linear embedding for classification/quantitative analysis. The proposed framework is based on the linear OT in continuous domain, together with the simple majority voting strategy with individual nucleus label predicted by KNN algorithm after discriminative projections. With nuclei morphological information alone, the method showed an accuracy of 81.3%, an improved classification with 6.4% gain in differentiating patients from benign or malignant in double cross-validations, compared with the commonly used numerical features. In addition, the distribution differences in nuclei morphology can be directly visualized along the discriminative geodesic generated by the penalized version of LDA (pLDA). In the analysis of large case samples (139 patients in our study), the proportions of representative nuclei along the pLDA direction for DN and MM are statistically different with meaningful biological interpretations, which agrees well with descriptions in the existing literatures and actual morphological measurements.

We also note that the potential reasons behind the improved classification accuracy of LOT in our study can be explained in two folds: (1) LOT performed in continuous domain is a reversible transformation. In other words, theoretically, one can reconstruct the original nucleus image without information loss given its corresponding linear embedding and the reference image. Such property enables the preservation of discriminative information when quantifying nuclei morphological characteristics for classification. On the contrary, numerical feature-based method usually prevents reconstruction of the input images from feature space, and the performance boosting requires more manually designed discriminative features involved to represent the nucleotyping. (2) The transformation from image domain to the LOT space is a nonlinear operation. As explained in the study by Rohde *et al*.,\[[@ref36]\] the nonlinearity has the potential to improve linear separability, and thus improves the classification accuracy in our study. Feature-based method, however, often contains a mixture of linear and nonlinear operations depending on the type of measurements we are interested in.

In the future, our work can be extended in the following aspects: first, fully automated and reliable nuclei detection and segmentation algorithms are required when a larger number of cases are involved in the study. WSI often constitutes of a mosaic of different kinds of cells (e.g., melanocytes and keratinocytes in our case) in various tissue types, which poses a huge challenge when analyzing a certain kind of cells in the nuclei-based cancer detection pipeline. Even if the nuclei of interest are located by pathologists, to the best of our knowledge, existing segmentation methods produce segmentation failures with different degrees, which may affect the classification performance when manually screening segmentations is impossible for large datasets. Second, alternative nonnaive Bayesian models need to be developed and applied to predict patient labels. In our experiment, patient-level labels are assigned through the majority voting strategy after predicting cell nuclei labels individually and independently. Though implicitly, such procedure actually follows the naive Bayesian model, where there is no assumed interdependency among cell nuclei. As shown in a study by Huang *et al*.,\[[@ref42]\] neglecting interdependencies between nearby nuclei can lead to suboptimal classification results.

Finally, our study shows that nucleotyping alone can obtain an accuracy of 81.3%. This suggests a practical, inexpensive solution, with similar accuracy like the current clinical dermascopes and molecular diagnostics. With further development and refined analysis, nucleotyping may be of prime use as a screening tool. Large data sets of digital images can be automatically screened and flagged for review as necessary. Ongoing research of new diagnostic characteristics can be used in combination with other modalities for increased accuracy in the diagnosis and prognosis of patients.

C[onclusions]{.smallcaps} {#sec1-5}
=========================

Our study visually identifies the distribution differences between MM and DN based on novel representations of nuclear morphology. Using WSI and the proposed LOT-based nuclei analysis framework, MM and DN are distinguishable with a better accuracy compared with numerical feature-based method. Nuclear image analysis in conjunction with next-generation sequencing or other feature-rich detection systems may increase diagnostic accuracy and has prognostic implications. The clinical and functional significance of nuclear chromatin morphologies in cancer has yet to be fully realized. Larger studies with combinations of other features and survival data are needed to draw further diagnostic and prognostic conclusions.
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